Redcare Pharmacy NV (WBO:SHOP)

€ 146.9 1.9 (1.31%) Market Cap: 2.96 Bil Enterprise Value: 2.99 Bil PE Ratio: 0 PB Ratio: 5.77 GF Score: 79/100

Q3 2024 Redcare Pharmacy NV Earnings Call Transcript
Nov 05, 2024

€146.8 (+3.82%)

Earnings
Half Year 2024 Redcare Pharmacy NV Earnings Call Transcript
Jul 30, 2024

€145.4 (+9.08%)

Earnings
Q1 2024 Redcare Pharmacy NV Earnings Call Transcript
Apr 25, 2024

€130.2 (-4.19%)

Earnings
Q2 2023 Redcare Pharmacy NV Earnings Call Transcript
Aug 01, 2023

€115.5 (+8.96%)

Earnings
Q1 2023 Shop Apotheke Europe NV Earnings Call Transcript
May 02, 2023

€88.36 (-5.90%)

Earnings
Q4 2022 Shop Apotheke Europe NV Earnings Call Transcript
Mar 07, 2023

€70.5 (-4.99%)

Earnings
Q3 2022 Shop Apotheke Europe NV Earnings Call Transcript
Oct 31, 2022

€42.21 (+1.64%)

Earnings
Q2 2022 Shop Apotheke Europe NV Earnings Call Transcript
Aug 03, 2022

€96.78 (-1.93%)

Earnings
Q1 2022 Shop Apotheke Europe NV Earnings Call Transcript
May 05, 2022

€89.02 (+1.64%)

Earnings
Q2 2021 Redcare Pharmacy NV Earnings Call Transcript
Aug 05, 2021

€121.5 (-0.25%)

Earnings

Q4 2022 Shop Apotheke Europe NV Earnings Call Transcript

Mar 07, 2023 / 10:00AM GMT

Release Date Price: €70.5 (-4.99%)

Transcript

Stefan Feltens

Shop Apotheke Europe N.V. - CEO

Well, thank you, and a warm welcome to all of you. Jasper and I would like to welcome you again to our earnings release call right here from our headquarters in Sevenum. But before jumping into the content of our presentation, I would like to say a few words about yesterday's announcement regarding my retirement from Shop Apotheke, following the upcoming annual general meeting at the end of April.

The last 4.5 years with Shop Apotheke have really been the highlight of my professional career. It has been a real privilege to serve this unique company, to work together with a great management team, but also to interact with many of you. It has also been a privilege to be able to witness and, within my means, to contribute to the tremendous growth of Shop Apotheke over the last few years.

Looking forward, there's really no doubt in my mind that Shop Apotheke will continue on its growth trajectory and that it will deliver on its promises as well as its potential. By the way, only one individual out of the team of five is leaving, so the other

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.